Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relations...
Journal Information
Vol. 147. Issue 6.
Pages 245-247 (September 2016)
Download PDF
More article options
Vol. 147. Issue 6.
Pages 245-247 (September 2016)
Brief report
Expression of miR-22 and miR-150 in type 1 diabetes mellitus: Possible relationship with autoimmunity and clinical characteristics
Expresión de miR-22 y miR-150 en diabetes mellitus tipo 1: posible asociación con autoinmunidad y características clínicas de la enfermedad
Santiago Estrellaa, Diego F. Garcia-Diaza, Ethel Codnerb, Patricia Camacho-Guilléna, Francisco Pérez-Bravoa,
Corresponding author

Corresponding author.
a Laboratorio de Nutrigenómica, Departamento de Nutrición, Facultad de Medicina, Universidad de Chile, Santiago, Chile
b Instituto de Investigaciones Materno Infantil (IDIMI), Hospital San Borja Arriarán, Facultad de Medicina, Universidad de Chile, Santiago, Chile
Article information
Full Text
Download PDF
Figures (2)
Tables (1)
Table 1. Clinical parameters and distribution of autoantibodies of patients with DM1 and controls.
Background and objective

Type 1 diabetes (T1D) is an autoimmune disease of complex aetiology. Several microRNAs (miR) have been linked to the pathogenesis of autoimmune diseases.

To analyze the possible association of miR-22 and miR-150 with autoimmunity and clinical severity of T1D.

Patients and methods

The study was performed in peripheral blood mononuclear cells of 20 patients with T1D and 20 control subjects. The expression of miR-22 and miR-150 was performed in peripheral blood mononuclear cells using TaqMan probes to different glucose concentrations (baseline, 11mm, 25mm).


Our results suggest that the expression of miR-22 is increased in T1D patients compared to the controls. This effect was observed in baseline glucose conditions and decreased in 11 and 25mM of glucose. The expression of miR-150 was lower in T1D patients versus the controls. There was no correlation between the autoimmune profile and the two studied miRNAs. miR-22 (baseline condition) and miR-150 (11mM condition) or the ketoacidosis component.


miR-22 and 150 were not associated with the autoimmune component present in T1D patients.

Type 1 diabetes

La diabetes tipo 1 (DM1) es una enfermedad autoinmune de etiología compleja. Diversos microARN (miR) han sido relacionados con la patogénesis de enfermedades autoinmunes.


Analizar la posible asociación de miR-22 y miR-150 con autoinmunidad y gravedad clínica en la DM1.

Pacientes y método

El estudio se realizó en células mononucleares periféricas de 20 pacientes con DM1 y 20 sujetos controles. La expresión de miR-22 y miR-150 se realizó por sondas TaqMan en células mononucleares periféricas a diferentes concentraciones de glucosa (basal, 11mM, 25mM).


Nuestros resultados muestran que la expresión de miR-22 está aumentada en pacientes con DM1 respecto de controles. Este efecto se observó en la condición basal de glucosa y disminuyó en condiciones 11 y 25mM de glucosa. La expresión de miR-150 fue menor en pacientes con DM1 versus controles. No hubo asociación de los niveles de miR-22 (condición basal) y miR-150 (condición 11mM) con el perfil de autoinmunidad ni la presencia de cetoacidosis.


miR-22 y miR-150 no se asocian a los niveles de autoanticuerpos, pero sí al componente de cetoacidosis en DM1.

Palabras clave:
Diabetes tipo 1


These are the options to access the full texts of the publication Medicina Clínica (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Medicina Clínica (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos